Through bioinformatics analysis, the survival probability in patients following CRC diagnosis and treatments was found to be negatively correlated with the protein expression levels of STK35, demonstrating that STK35 could be an indicator of CRC tumor recurrence. Here, STK35 is linked to neoplasm.